These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31071457)

  • 1. Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.
    Pasquini MC; Srivastava A; Ahmed SO; Aljurf M; Atsuta Y; Doleysh C; Galeano S; Gluckman E; Greinix H; Hale GA; Hari P; Hashmi SK; Kamani N; Laughlin MJ; Niederwieser D; Seber A; Szer J; Snowden JA; Van Biesen K; Watry P; Weisdorf DJ; Apperley J
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2322-2329. PubMed ID: 31071457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.
    Pasquini MC; Srivastava A; Ahmed SO; Aljurf M; Atsuta Y; Doleysh C; Galeano S; Gluckman E; Greinix H; Hale G; Hari P; Hashmi SK; Kamani N; Laughlin MJ; Niederwieser D; Seber A; Szer J; Snowden JA; Van Biesen K; Watry P; Weisdorf DJ; Apperley J
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):131-142. PubMed ID: 31449780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program.
    El Fakih R; Greinix H; Koh M; Shaw B; Mohty M; Al Nahedh M; Saber W; Kharfan-Dabaja MA; Perales MA; Savani BN; Majhail NS; Passweg JR; Sureda A; Ahmed SO; Gluckman E; Riches M; El-Jawahri A; Rondelli D; Srivastava A; Faulkner L; Atsuta Y; Ballen KK; Rasheed W; Okamoto S; Seber A; Chao N; Kröger N; Kodera Y; Szer J; Hashmi SK; Horowitz MM; Weisdorf D; Niederwieser D; Aljurf M
    Transplant Cell Ther; 2021 Mar; 27(3):267.e1-267.e5. PubMed ID: 33781535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
    Aljurf M; Weisdorf D; Hashmi S; Nassar A; Gluckman E; Mohty M; Rizzo D; Pasquini M; Hamadani M; Saber W; Hari P; Kharfan-Dabaja M; Majhail N; Gerges U; Hamidieh AA; Hussain F; Elhaddad A; Mahmoud HK; Tbakhi A; Othman TB; Hamladji RM; Bekadja MA; Ahmed P; Bazarbachi A; Adil S; Alkindi S; Ladeb S; Dennison D; Patel M; Lu P; Quessar AE; Okamoto S; Atsuta Y; Alhejazi A; Ayas MF; Ahmed SO; Novitzky N; Srivastava A; Seber A; Solh HE; Ghavamzadeh A; Confer D; Kodera Y; Hildegard G; Szer J; Horowitz MM; Niederwieser D
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2330-2337. PubMed ID: 31002990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.
    Majhail NS; Farnia SH; Carpenter PA; Champlin RE; Crawford S; Marks DI; Omel JL; Orchard PJ; Palmer J; Saber W; Savani BN; Veys PA; Bredeson CN; Giralt SA; LeMaistre CF
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1863-1869. PubMed ID: 26256941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.
    Aljurf M; Weisdorf D; Hashmi SK; Nassar A; Gluckman E; Mohty M; Rizzo D; Pasquini M; Hamadani M; Saber W; Hari P; Kharfan-Dabaja M; Majhail N; Gerges U; Hamidieh AA; Hussain F; Elhaddad A; Mahmoud HK; Tbakhi A; Othman TB; Hamladji RM; Bekadja MA; Ahmed P; Bazarbachi A; Adil S; Alkindi S; Ladeb S; Dennison D; Patel M; Lu P; Quessar AE; Okamoto S; Atsuta Y; Alhejazi A; Ayas M; Ahmed SO; Novitzky N; Srivastava A; Seber A; Elsolh H; Ghavamzadeh A; Confer D; Kodera Y; Greinix H; Szer J; Horowitz M; Niederwieser D
    Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):7-16. PubMed ID: 31449781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
    Shah N; Callander N; Ganguly S; Gul Z; Hamadani M; Costa L; Sengsayadeth S; Abidi M; Hari P; Mohty M; Chen YB; Koreth J; Landau H; Lazarus H; Leather H; Majhail N; Nath R; Osman K; Perales MA; Schriber J; Shaughnessy P; Vesole D; Vij R; Wingard J; Giralt S; Savani BN;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1155-66. PubMed ID: 25769794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
    Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.
    Hashmi SK; Srivastava A; Rasheed W; Adil S; Wu T; Jagasia M; Nassar A; Hwang WYK; Hamidieh AA; Greinix HT; Pasquini MC; Apperley JF; Aljurf M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):167-172. PubMed ID: 28732192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
    Perales MA; Ceberio I; Armand P; Burns LJ; Chen R; Cole PD; Evens AM; Laport GG; Moskowitz CH; Popat U; Reddy NM; Shea TC; Vose JM; Schriber J; Savani BN; Carpenter PA;
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):971-83. PubMed ID: 25773017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
    Algwaiz G; Aljurf M; Koh M; Horowitz MM; Ljungman P; Weisdorf D; Saber W; Kodera Y; Szer J; Jawdat D; Wood WA; Brazauskas R; Lehmann L; Pasquini MC; Seber A; Lu PH; Atsuta Y; Riches M; Perales MA; Worel N; Okamoto S; Srivastava A; Chemaly RF; Cordonnier C; Dandoy CE; Wingard JR; Kharfan-Dabaja MA; Hamadani M; Majhail NS; Waghmare AA; Chao N; Kröger N; Shaw B; Mohty M; Niederwieser D; Greinix H; Hashmi SK;
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2181-2189. PubMed ID: 32717432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].
    Zephir H; Puyade M; Gueguen A; Michel L; Terriou L; Dive D; Laureys G; Mathey G; Labauge P; Marjanovic Z; Pugnet G; Badoglio M; Lansiaux P; Yakoub-Agha I; Béguin Y; Farge D
    Bull Cancer; 2019 Jan; 106(1S):S92-S101. PubMed ID: 30527815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
    Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
    Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.